16S rRNA Gene Sequencing of Gut Microbiota in Rheumatoid Arthritis Treated with 99Tc-MDP
Zhaowei Huang,Changming Chen,Linlin Tan,Yi Ling,Wukai Ma,Jinan Zhang
DOI: https://doi.org/10.2147/pgpm.s451065
2024-05-23
Pharmacogenomics and Personalized Medicine
Abstract:Zhaowei Huang, 1, 2, &ast Changming Chen, 3, &ast Linlin Tan, 4 Yi Ling, 3 Wukai Ma, 3 Jinan Zhang 1, 2 1 Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 2 Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, People's Republic of China; 3 Department of Rheumatology & Immunology, The Second Affiliated Hospital of Guizhou University of Chinese Medicine, Guiyang, Guizhou, People's Republic of China; 4 Department of Internal Medicine, Jinshazhou Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jinan Zhang, Email Background: Rheumatoid arthritis (RA) is a common autoimmune disease with the main symptoms being joint swelling and pain. In severe cases, joint deformity or even complete loss of function occurs. Technetium methylene diphosphonate (99Tc-MDP) is widely used for RA treatment in China, but there are no studies on the effects of 99Tc-MDP on intestinal flora. Objective: To explore the effects of 99Tc-MDP treatment on the composition and function of the intestinal flora and to provide new information on the mechanism of 99Tc-MDP in RA treatment. Methods: Stool samples from RA patients before and after 99Tc-MDP treatment were collected to form two groups (Before and After). Total genomic DNA of the samples was extracted for 16S rRNA gene sequencing. The altered composition of the intestinal flora, the key target bacteria regulated by 99Tc-MDP, and the pathways of action of 99 Tc-MDP were analyzed by bioinformatics. Results: A total of 64 fresh stool samples were collected from 32 RA patients. Compared to the Before group, the After group showed increased Bacteroidetes abundance and decreased Firmicutes abundance. At the genus level, Prevotella increased whereas Escherichia decreased. Both α and β diversity analyses showed that 99Tc-MDP treatment did not affect gut microbial diversity in RA patients. LEfSe analyses and random forest analyses showed Bacteroidetes, Prevotella, Enterococcus, Escherichia and Ruminococcaceae were the main 99Tc-MDP regulating bacteria. Functional enrichment analysis revealed that the functional differences in gut flora of the two groups centered on Metabolism and Genetic Information Processing. Conclusion: This study revealed differences in the composition of the gut microbiota in RA patients before and after 99Tc-MDP treatment. The therapeutic effect of 99Tc MDP is mainly achieved through Bacteroidetes, Prevotella, and Enterococcus. Regulating metabolism and genetic information processing of gut flora may be the mechanism of 99Tc-MDP in treating RA. Keywords: rheumatoid arthritis, 99Tc-MDP, gut microbiota, 16S rRNA, bioinformatics Rheumatoid arthritis (RA) is a systemic autoimmune disease. As the disease progresses, it will cause the gradual loss of joint function, which will seriously affect the life and work of patients. The global prevalence of RA is about 1%, with a much higher incidence in women than in men. 1 Although the pathogenesis of RA is unclear, scholars agree that it is closely related to environmental factors, genetic susceptibility, and immune dysfunction. Gut microbes happen to interact closely with all the three. 2–4 Lifestyle, dietary preferences, and gut flora metabolites affect the development and prognosis of RA. 3,5 Meanwhile, the RA susceptibility gene HLA-DRB1 favors a more inflammatory gut microbiome. 6 In addition, gut microbes are indispensable for the maturation of the immune system, especially mucosa-associated lymphoid tissue. 7 In recent years, with the development of high-throughput sequencing technologies, more and more evidence has shown that the pathogenesis of RA is closely related to the host gut microbiota, especially in the induction of chronic inflammation and activation of autoimmunity. 8,9 Technetium methylene diphosphonate (99Tc-MDP) is a nuclide preparation, and its main component is the complex formed by the trace element technetium and methylene diphosphonic acid (Indications: RA and orthopaedic diseases). 99Tc-MDP has strong anti-inflammatory and bone repair effects, and at the same time has high safety. It is often used in the treatment of RA in China. 10–12 99Tc-MDP can also reduce the secretion of inflammatory cytokines such as TNF-α and IL-6 by regulating immune cells. 13,14 Clinically, 99Tc-MDP is often used -Abstract Truncated-
pharmacology & pharmacy